Seastar Medical Holding Received FDA Approval Order For The Usage Of Selective Cytopheretic Device Pediatric In Children Weighing 10 Kilograms Or More With Acute Kidney Injury Due To Sepsis Or A Septic Condition Requiring Kidney Replacement Therapy
Author: Benzinga Newsdesk | February 22, 2024 08:56am